Trial · NCT04622735
Results by group138
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 138
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Ranked Endpoints : 1. Sum of Pain Intensity Differences at 6 Hours (SPID0-6h) | Fixed Dose Combination Nefopam Hydrochloride 30 mg / Paracetamol 500 mg (X2) | 8955.4 | Standard Deviation 8751.8 | score on a scale | |
| Ranked Endpoints : 1. Sum of Pain Intensity Differences at 6 Hours (SPID0-6h) | Paracetamol 500 mg (X2) | 8458.0 | Standard Deviation 8831.7 | score on a scale | |
| Ranked Endpoints : 1. Sum of Pain Intensity Differences at 6 Hours (SPID0-6h) | Nefopam Hydrochloride 30 mg (X2) | 5290.7 | Standard Deviation 9109.3 | score on a scale | |
| Total Pain Relief at 6 Hours (TOTPAR0-6h) | Fixed Dose Combination Nefopam Hydrochloride 30 mg / Paracetamol 500 mg (X2) | 610.6 | Standard Deviation 434.5 | score on a scale | |
| Total Pain Relief at 6 Hours (TOTPAR0-6h) | Paracetamol 500 mg (X2) | 602.2 | Standard Deviation 383.6 | score on a scale | |
| Total Pain Relief at 6 Hours (TOTPAR0-6h) | Nefopam Hydrochloride 30 mg (X2) | 461.4 | Standard Deviation 384.5 | score on a scale | |
| Proportion of Responder Patients | FDC Nefopam Hydrochloride 30 mg / Paracetamol 500 mg (X2) | 47 | Participants | ||
| Proportion of Responder Patients | Paracetamol 500 mg (X2) | 43 | Participants | ||
| Proportion of Responder Patients | Nefopam Hydrochloride 30 mg (X2) | 35 | Participants | ||
| The Patient's Global Impression of Change (PGIC) Questionnaire | FDC Nefopam Hydrochloride 30 mg / Paracetamol 500 mg (X2) | VERY MUCH IMPROVED | 11 | Participants | |
| The Patient's Global Impression of Change (PGIC) Questionnaire | Paracetamol 500 mg (X2) | VERY MUCH IMPROVED | 14 | Participants | |
| The Patient's Global Impression of Change (PGIC) Questionnaire | Nefopam Hydrochloride 30 mg (X2) | VERY MUCH IMPROVED | 11 | Participants | |
| The Patient's Global Impression of Change (PGIC) Questionnaire | FDC Nefopam Hydrochloride 30 mg / Paracetamol 500 mg (X2) | MUCH IMPROVED | 39 | Participants | |
| The Patient's Global Impression of Change (PGIC) Questionnaire | Paracetamol 500 mg (X2) | MUCH IMPROVED | 29 | Participants | |
| The Patient's Global Impression of Change (PGIC) Questionnaire | Nefopam Hydrochloride 30 mg (X2) | MUCH IMPROVED | 30 | Participants | |
| The Patient's Global Impression of Change (PGIC) Questionnaire | FDC Nefopam Hydrochloride 30 mg / Paracetamol 500 mg (X2) | MINIMALLY IMPROVED | 22 | Participants | |
| The Patient's Global Impression of Change (PGIC) Questionnaire | Paracetamol 500 mg (X2) | MINIMALLY IMPROVED | 24 | Participants | |
| The Patient's Global Impression of Change (PGIC) Questionnaire | Nefopam Hydrochloride 30 mg (X2) | MINIMALLY IMPROVED | 31 | Participants | |
| The Patient's Global Impression of Change (PGIC) Questionnaire | FDC Nefopam Hydrochloride 30 mg / Paracetamol 500 mg (X2) | NO CHANGE | 14 | Participants | |
| The Patient's Global Impression of Change (PGIC) Questionnaire | Paracetamol 500 mg (X2) | NO CHANGE | 12 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04622735/results